CRITICALFEDAesthetic InjectablesJul 16, 2026
FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
FDA refuses entry of OnabotulinumtoxinA from Ireland.
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
Why FDA refused this
FDA refused this shipment at the U.S. border from Allergan Pharmaceuticals Ireland (Westport), classified by FDA as Human and Animal Therapeutic Biologic and Biosimilar Drugs.
FDA does not publish plain-language definitions for this shipment’s device charge codes. Verify on the FDA firm profile ↗
FDA Import Refusal · FDA firm profile ↗FDA record · Allergan Pharmaceuticals Ireland · Westport · drug product · refused entry by FDA
Related alerts
- FDA import refusal: Lidocaine Hcl (Anesthetic) (India)
- FDA import refusal: Daxxify (daxibotulinumtoxinA)-LANM
- FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
- FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
- FDA import refusal: Botox (onabotulinumtoxinA) (United Kingdom)
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
Monitoring, not legal advice.